Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancer.
Benjamin
B
Solomon
Danny
D
Rischin
D018278:Carcinoma, Neuroendocrine; D005260:Female; D006801:Humans; D008297:Male; D010880:Piperidines / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000188:drug therapy*
D010880:Piperidines; D011799:Quinazolines; C452423:vandetanib